U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs
Posted inBiotechnology and Bioengineering Cancer China Cystic Fibrosis Delaware Drugs (Pharmaceuticals) Eli Lilly and Company Factories and Manufacturing GlaxoSmithKline PLC Government Contracts and Procurement House of Representatives Intellectual Property Janssen Pharmaceutica Labor and Jobs Leukemia Massachusetts People's Liberation Army (China) Research Senate Shortages Start-ups Supply Chain Tax Credits, Deductions and Exemptions United States International Relations United States Politics and Government

U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs

Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
The Politics of a Steel Deal Hangs Over Biden’s Japan Summit
Posted inBiden, Joseph R Jr Customs (Tariff) internal-storyline-no Japan Kishida, Fumio Nippon Steel Corporation Pennsylvania Politics and Government Presidential Election of 2024 Trump, Donald J United States International Relations United States Steel Corporation

The Politics of a Steel Deal Hangs Over Biden’s Japan Summit

The president’s effort to court voters in crucial swing states is influencing economic and trade policy, and worrying longstanding allies.
Biden’s Trade Moves Raise Tensions With China and Japan but Draw Cheers at Home
Posted inBiden, Joseph R Jr Brown, Sherrod China Factories and Manufacturing Japan Kishida, Fumio Labor and Jobs Mergers, Acquisitions and Divestitures Nippon Steel Corporation Protectionism (Trade) Steel and Iron United States International Relations United States Politics and Government United States Steel Corporation United Steelworkers of America

Biden’s Trade Moves Raise Tensions With China and Japan but Draw Cheers at Home

The president’s efforts to restrict Chinese imports and block a Japanese steel merger have pleased labor unions and sent a message to rival Donald J. Trump.
As Jared Kushner’s Investment Firm Steps Out, the Potential Conflicts Are Growing
Posted inConflicts of Interest Ethics and Official Misconduct Kushner, Jared Trump, Donald J United States International Relations United States Politics and Government

As Jared Kushner’s Investment Firm Steps Out, the Potential Conflicts Are Growing

Jared Kushner’s Affinity Partners has invested more than $1.2 billion, much of it in firms abroad, drawing new scrutiny as his father-in-law, Donald Trump, again seeks the presidency.